Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
3.010
+0.080 (2.73%)
At close: Jan 31, 2025, 4:00 PM
3.020
+0.010 (0.33%)
After-hours: Jan 31, 2025, 4:57 PM EST
Mereo BioPharma Group Revenue
Mereo BioPharma Group had revenue of $1.00M in the twelve months ending September 30, 2024, down -88.89% year-over-year. In the year 2023, Mereo BioPharma Group had annual revenue of $10.00M.
Revenue (ttm)
$1.00M
Revenue Growth
-88.89%
P/S Ratio
n/a
Revenue / Employee
$30,303
Employees
33
Market Cap
466.24M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
Novartis AG | 51.72B |
AstraZeneca | 51.21B |
Thermo Fisher Scientific | 42.88B |
Abbott Laboratories | 41.95B |
MREO News
- 19 days ago - Mereo BioPharma Provides Update on Lead Clinical Programs - GlobeNewsWire
- 25 days ago - Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Mereo BioPharma: Setrusumab Chugs Along With Possible Inflection Points - Seeking Alpha
- 2 months ago - Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference - GlobeNewsWire
- 2 months ago - Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 6 months ago - Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 8 months ago - Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market - GlobeNewsWire